Bausch Execs Try To Nix Derivative Suit Over Fraud Scheme
Bausch Health Cos. Inc. executives urged a New Jersey federal judge to toss a shareholder derivative suit over their alleged cover-up of the Canadian pharmaceutical company's purported price-gouging scheme, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article